Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety monitoring of single low-dose primaquine co-administered with artemether-lumefantrine in routine malaria care
PACTR202007653561223Phase 3Completed
- Sponsor
- Ifakara Health Institute
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of primaquine and artemether + lumefantrine in Malaria, sponsored by Ifakara Health Institute. Primary endpoint: Healthcare worker compliance with PROMPT. Started Mar 2020; status: completed.
02
Drugs
primaquineartemether + lumefantrine
03
Conditions
Malaria
Beyond the preview
Go deeper on PACTR202007653561223.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR202007653561223.